Joint Logo.png
Cancer Genetics and StemoniX Announce Joint Proof-of-Concept Program
September 03, 2020 08:00 ET | Cancer Genetics, Inc.
RUTHERFORD, N.J., and MAPLE GROVE, MN, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, and...